Waters BioAccord LC-MS System

Overview

The Waters BioAccord LC-MS System is a purpose-built, integrated liquid chromatography–mass spectrometry platform engineered for biopharmaceutical characterization and quality control. Leveraging time-of-flight (TOF) mass spectrometry with high mass accuracy, high resolution, and broad dynamic range, the system delivers robust molecular weight determination, intact protein analysis, subunit characterization, peptide mapping, and glycan profiling—without requiring expert-level MS operator intervention. At its core lies the ACQUITY RDa mass detector, a compact, sealed TOF analyzer optimized for routine biopharma labs where reproducibility, uptime, and regulatory readiness are non-negotiable. The system operates on the principle of orthogonal acceleration TOF (oa-TOF), enabling precise m/z measurement across 50–10,000 Da with <5 ppm mass accuracy (calibrated) and sub-20,000 resolving power (FWHM at m/z 1,000). Unlike traditional research-grade TOF platforms, BioAccord integrates hardware, consumables, software, and support into a single validated workflow—designed to function as a production-ready instrument from day one.

Key Features

• SmartMS-enabled automation: Fully automated calibration, source optimization, and diagnostic self-checks reduce manual intervention and eliminate method-dependent tuning.
• ACQUITY RDa TOF detector: Sealed, vacuum-integrated time-of-flight analyzer with no user-accessible ion optics; engineered for >95% uptime in 24/7 QC environments.
• ACQUITY UPLC I-Class PLUS: Ultra-low dispersion LC module with <10 µL total system volume and <200 nL dwell volume—optimized for narrow peak elution and maximal MS sensitivity.
• Plug-and-play ESI source: Fixed geometry, non-adjustable electrospray ionization interface with pre-aligned, thermally stabilized probe—designed for consistent ionization efficiency across thousands of injections.
• UNIFI Scientific Information System: Unified platform for instrument control, data acquisition, processing, reporting, and audit-trail management—all within a single FDA 21 CFR Part 11–compliant environment.
• Pre-validated application packages: Pre-configured methods and certified reference standards for intact mAb analysis, reduced antibody subunits, peptide mapping, and N-glycan release/analysis.

Sample Compatibility & Compliance

The BioAccord system supports diverse biopharmaceutical sample types—including intact monoclonal antibodies (mAbs), antibody–drug conjugates (ADCs), fusion proteins, bispecifics, and recombinant enzymes—across concentration ranges from 0.1–5 mg/mL. It accommodates standard vial formats (e.g., Waters 186008793, 2 mL crimp-top), microtiter plate configurations (96-well), and direct infusion via syringe pump for rapid screening. All hardware and software components comply with ISO 9001:2015 and IEC 61010-1 safety standards. UNIFI implements full ALCOA+ principles (Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, Available) and supports 21 CFR Part 11 electronic signatures, role-based access control, and immutable audit trails for GxP-regulated environments. Method validation documentation aligns with ICH Q5E, Q5B, and USP guidance for structural characterization.

Software & Data Management

UNIFI serves as the central informatics hub, unifying instrument control, data acquisition, processing, and reporting in a single architecture. It features automated sequence setup, real-time spectral quality monitoring, and intelligent peak detection algorithms trained on biopharma-relevant spectra. Each analysis generates a complete digital record—including raw data (.raw), processed results (.uresult), metadata, and system suitability reports—stored in a relational SQL database with configurable retention policies. Health Status Cards provide contextual diagnostics: if signal suppression or mass drift is detected, UNIFI displays root-cause analysis and step-by-step remediation instructions. All user actions—including parameter edits, reprocessing events, and report generation—are captured in a tamper-evident audit trail compliant with GLP and GMP requirements. Integration with Waters’ Empower 3 and third-party LIMS is supported via standardized APIs and ASTM E1384-compliant data exchange protocols.

Applications

• Intact mass analysis of therapeutic proteins under native and denatured conditions
• Reduced and non-reduced subunit characterization for disulfide bond mapping
• Peptide mapping workflows including deamidation, oxidation, and sequence variant detection
• N- and O-linked glycan profiling using released glycan standards and exoglycosidase digestions
• Comparability studies across process changes, cell line variants, or manufacturing sites
• Stability-indicating assays tracking degradation pathways over time

The system is routinely deployed in upstream development, formulation support, release testing, and comparability assessments—supporting both early-phase candidate selection and commercial batch release per pharmacopeial monographs (e.g., USP , EP 2.2.44).

FAQ

Is the BioAccord system suitable for regulated QC laboratories?
Yes—it is designed and validated for use in GMP-compliant environments, with full 21 CFR Part 11 compliance, electronic signature support, and documented IQ/OQ/PQ protocols available through Waters Professional Services.
Does the system require daily manual tuning or calibration?
No—SmartMS performs automated mass calibration and sensitivity optimization before each sequence, eliminating manual tuning and ensuring inter-day reproducibility without operator dependency.
Can UNIFI be used for multi-user collaboration and data sharing?
Yes—UNIFI supports centralized server deployment with project-level permissions, version-controlled method libraries, and cross-lab result comparison dashboards.
What level of technical support is included with purchase?
All BioAccord systems include Waters’ Platinum Support package: 24/7 remote diagnostics, priority on-site service response, scheduled preventive maintenance, and access to application scientists for method development consultation.
Are application-specific consumables supplied with the system?
Yes—initial consumables kits include bio-inert UPLC columns (e.g., BEH C4, CSH C18), biopharma-certified standards (e.g., mAb Standard, GlycoWorks RapiFluor-MS Kit), and validated vials/caps—all traceable to NIST SRMs and accompanied by CoA documentation.